Noa has diverse experience in various biotechnological domains. Noa independently led multiple projects at MeMed Diagnostics combining scientific, technological and industrial challenges in various product stages including product development, transfer to GMP manufacturing, and FDA approval processes of a novel multi-parametric immunoassay product and its integration with a novel Point-Of-Care measurement.
Noa also led various R&D, Bioanalytical and Preclinical activities at NanoGhost and Minovia Therapeutics- startups developing a novel drug delivery system based on Mesenchymal Stem Cells, and Mitochondrial therapies respectively.
Noa has a strong background in protein biochemistry, and received her Ph.D. at the Technion Institute Of Technology under the supervision of Noble Prize Laureate (Chemistry), Prof. Aaron Ciechanover.
